IRhythm Technologies Shares Rise After Narrower-Than-Expected 4Q Loss

Dow Jones02-21

By Chris Wack

Shares of IRhythm Technologies were up after the digital-healthcare company posted a fourth-quarter loss that was narrower than analysts expected.

IRhythm's stock was 8.2% higher, at $121.89, Friday morning. It has gained about 35% so far this year.

The San Francisco company on Thursday reported a loss of $1.3 million, or 4 cents a share. Analysts polled by FactSet were looking for a loss of $8.9 million, or 33 cents a share.

Revenue for the quarter was $164.3 million, ahead of the $158.1 million analysts were expecting.

IRhythm said its increase in fourth-quarter revenue was driven by sustained volume demand across all customer channels and cited specifically increases in the volume of its Zio Services. Its Zio platform is a wearable cardiac-monitoring system that helps diagnose arrhythmias.

The company expects 2025 revenue of $675 million to $685 million, while analysts are forecasting revenue of $681.4 million.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

February 21, 2025 11:13 ET (16:13 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2513297850?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-22 00:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2513297850","market":"fut","top_or_hot":-1,"title":"IRhythm Technologies Shares Rise After Narrower-Than-Expected 4Q Loss","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of IRhythm Technologies were up after the digital-healthcare company posted a fourth-quarter loss that was narrower than analysts expected. \n</p>\n<p>\n  IRhythm's stock was 8.2% higher, at $121.89, Friday morning. It has gained about 35% so far this year. \n</p>\n<p>\n  The San Francisco company on Thursday reported a loss of $1.3 million, or 4 cents a share. Analysts polled by FactSet were looking for a loss of $8.9 million, or 33 cents a share. \n</p>\n<p>\n  Revenue for the quarter was $164.3 million, ahead of the $158.1 million analysts were expecting. \n</p>\n<p>\n  IRhythm said its increase in fourth-quarter revenue was driven by sustained volume demand across all customer channels and cited specifically increases in the volume of its Zio Services. Its Zio platform is a wearable cardiac-monitoring system that helps diagnose arrhythmias. \n</p>\n<p>\n  The company expects 2025 revenue of $675 million to $685 million, while analysts are forecasting revenue of $681.4 million. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 21, 2025 11:13 ET (16:13 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IRhythm Technologies Shares Rise After Narrower-Than-Expected 4Q Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIRhythm Technologies Shares Rise After Narrower-Than-Expected 4Q Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-22 00:13</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of IRhythm Technologies were up after the digital-healthcare company posted a fourth-quarter loss that was narrower than analysts expected. \n</p>\n<p>\n  IRhythm's stock was 8.2% higher, at $121.89, Friday morning. It has gained about 35% so far this year. \n</p>\n<p>\n  The San Francisco company on Thursday reported a loss of $1.3 million, or 4 cents a share. Analysts polled by FactSet were looking for a loss of $8.9 million, or 33 cents a share. \n</p>\n<p>\n  Revenue for the quarter was $164.3 million, ahead of the $158.1 million analysts were expecting. \n</p>\n<p>\n  IRhythm said its increase in fourth-quarter revenue was driven by sustained volume demand across all customer channels and cited specifically increases in the volume of its Zio Services. Its Zio platform is a wearable cardiac-monitoring system that helps diagnose arrhythmias. \n</p>\n<p>\n  The company expects 2025 revenue of $675 million to $685 million, while analysts are forecasting revenue of $681.4 million. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 21, 2025 11:13 ET (16:13 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2513297850","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2513297850","pubTimestamp":1740154380,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of IRhythm Technologies were up after the digital-healthcare company posted a fourth-quarter loss that was narrower than analysts expected.IRhythm's stock was 8.2% higher, at $121.89, Friday morning. It has gained about 35% so far this year.The San Francisco company on Thursday reported a loss of $1.3 million, or 4 cents a share. Analysts polled by FactSet were looking for a loss of $8.9 million, or 33 cents a share.Revenue for the quarter was $164.3 million, ahead of the $158.1 million analysts were expecting.IRhythm said its increase in fourth-quarter revenue was driven by sustained volume demand across all customer channels and cited specifically increases in the volume of its Zio Services. Its Zio platform is a wearable cardiac-monitoring system that helps diagnose arrhythmias.The company expects 2025 revenue of $675 million to $685 million, while analysts are forecasting revenue of $681.4 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","IRTC":"Irhythm Technologies Inc.","BK4563":"昨日强势股"},"translate_title":"IRhythm Technologies第四季度亏损收窄后股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IRTC":0.9},"content_text":"By Chris Wack \n\n\n \n\n\n  Shares of IRhythm Technologies were up after the digital-healthcare company posted a fourth-quarter loss that was narrower than analysts expected. \n\n\n  IRhythm's stock was 8.2% higher, at $121.89, Friday morning. It has gained about 35% so far this year. \n\n\n  The San Francisco company on Thursday reported a loss of $1.3 million, or 4 cents a share. Analysts polled by FactSet were looking for a loss of $8.9 million, or 33 cents a share. \n\n\n  Revenue for the quarter was $164.3 million, ahead of the $158.1 million analysts were expecting. \n\n\n  IRhythm said its increase in fourth-quarter revenue was driven by sustained volume demand across all customer channels and cited specifically increases in the volume of its Zio Services. Its Zio platform is a wearable cardiac-monitoring system that helps diagnose arrhythmias. \n\n\n  The company expects 2025 revenue of $675 million to $685 million, while analysts are forecasting revenue of $681.4 million. \n\n\n \n\n\n  Write to Chris Wack at chris.wack@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 21, 2025 11:13 ET (16:13 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2513297850"}